TrialMuscle & nerve2022

Single- and multiple-dose safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of ASP0367, or bocidelpar sulfate, a novel modulator of peroxisome proliferator-activated receptor delta in healthy adults: Results from a phase 1 study.

Mototsugu Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.